Kyntra Bio, Inc. (KYNB)
6.58
-0.21
(-3.09%)
USD |
NASDAQ |
Mar 26, 12:44
Kyntra Bio Cash from Investing (Quarterly) : -51.71M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 1.699M |
| Perspective Therapeutics, Inc. | 28.54M |
| Gossamer Bio, Inc. | 73.16M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -37.17M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.33M |
| Cash from Financing (Quarterly) | -0.014M |
| Free Cash Flow | -4.858M |
| Free Cash Flow Per Share (Quarterly) | -4.530 |
| Free Cash Flow to Equity (Quarterly) | -16.85M |
| Free Cash Flow to Firm (Quarterly) | -15.92M |
| Free Cash Flow Yield | -2.61% |